These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24288702)

  • 21. Grading the new US Preventive Services Task Force prostate cancer screening recommendation.
    Volk RJ; Wolf AM
    JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540
    [No Abstract]   [Full Text] [Related]  

  • 22. USPSTF finds little evidence to support advising PSA screening in any man.
    Slomski A
    JAMA; 2011 Dec; 306(23):2549-51. PubMed ID: 22187266
    [No Abstract]   [Full Text] [Related]  

  • 23. 'Free' prostate cancer screens can be costly.
    Consum Rep; 2011 May; 76(5):12. PubMed ID: 21513002
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does PSA testing hurt or help?
    Johns Hopkins Med Lett Health After 50; 2012 Aug; 24(7):6. PubMed ID: 23033557
    [No Abstract]   [Full Text] [Related]  

  • 26. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
    Malli G
    Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: optimization of PSA screening policies: a comparison of the patient and societal perspectives.
    Penson DF
    J Urol; 2013 Feb; 189(2):529-30. PubMed ID: 23312159
    [No Abstract]   [Full Text] [Related]  

  • 28. The new PSA report: understand the controversy.
    Harv Mens Health Watch; 2012 Feb; 16(7):1-4. PubMed ID: 22474703
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
    Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
    Bratt O; Grenabo L
    Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
    [No Abstract]   [Full Text] [Related]  

  • 31. [Focus on the screening for prostate cancer by PSA].
    Roumeguère T; Van Velthoven R
    Rev Med Brux; 2013 Sep; 34(4):311-9. PubMed ID: 24195246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspective on...the new PSA screening recommendations.
    Marsland T; Arena F; Yeilding A; Glodé M; Ellis L; Yu J; Henderson C; Wagman L; Piver S; Minsky B; Rosen S; Poplack D; Potters L; Crawford D; Hoskins W
    Oncology (Williston Park); 2011 Nov; 25(12):1183, 1187-8, 1190. PubMed ID: 22229211
    [No Abstract]   [Full Text] [Related]  

  • 35. Deciding on PSA-screening - Quality of current consumer information on the Internet.
    Korfage IJ; van den Bergh RC; Essink-Bot ML
    Eur J Cancer; 2010 Nov; 46(17):3073-81. PubMed ID: 21047589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.
    Shimbo M; Tomioka S; Sasaki M; Shima T; Suzuki N; Murakami S; Nakatsu H; Shimazaki J
    Jpn J Clin Oncol; 2009 Nov; 39(11):727-31. PubMed ID: 19674994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Navigating the PSA screening dilemma.
    Jacobson J
    Am J Nurs; 2013 Jan; 113(1):19-21. PubMed ID: 23271238
    [No Abstract]   [Full Text] [Related]  

  • 38. [Screening for prostate cancer: an up date].
    Ito K
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):33-7. PubMed ID: 22241351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To screen or not to screen: ongoing debate in the early detection of prostate cancer.
    Marroquin JM
    Clin J Oncol Nurs; 2011 Feb; 15(1):97-8. PubMed ID: 21278045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.
    Colli JL; Amling CL
    Prostate Cancer Prostatic Dis; 2008; 11(3):247-51. PubMed ID: 18268527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.